Does PDRN Eye Cream Actually Firm Sagging Eyelids and Smooth Wrinkles? What the Evidence Shows

PDRN eye cream is a topical cosmetic formulation containing polydeoxyribonucleotide — purified DNA fragments — designed to reduce periocular wrinkles, improve skin firmness, and visibly lift the eye area. The best available controlled evidence, a 2026 randomized, double-blind, split-face trial published in PLOS ONE, found that a 0.1% medium-length PDRN eye cream reduced crow's-feet wrinkle area by up to 23% in 28 days, compared with roughly 6–7% for an identically formulated 0.1% retinol cream. That is a striking result, but it attaches to one specific preparation, not to the four letters on every bottle.

Before diving into the science, here is a side-by-side look at the key claims, the evidence behind them, and what a real-world product like The Ordinary Lacto-PDRN 4% + B9 Eye Cream actually delivers:

Feature	What the 2026 PDRN Trial Found	What The Ordinary Lacto-PDRN 4% + B9 Delivers	Key Caveat
Crow's-feet reduction	Up to −23% wrinkle area at day 28	Temporary smoothing via film-formers (pullulan, acacia gum)	Trial used 0.1% salmon-derived PDRN-850K; The Ordinary uses a vegan fermented version at an undisclosed pure PDRN concentration
Skin elasticity improvement	+44.0% on PDRN side vs. +24.8% retinol side	Not independently measured; moisturisation from glycerin and shea oil contributes	Elasticity gains in the trial were instrument-measured over 28 days; cosmetic feel ≠ structural change
Dermal thickness increase	+11.5% (PDRN) vs. +5.5% (retinol) by ultrasound	Not claimed or measured	Requires a specific molecular weight and delivery system to penetrate the dermis
Instant tightening	Not a focus of the trial	Yes — pullulan and Acacia Senegal Gum form a temporary film	Effect disappears on washing; no lasting structural change
Tolerability	No adverse reactions reported in 31 participants	Fragrance-free; well-tolerated gel-cream texture	Trial participants had self-reported sensitive skin
Price	Research-grade preparation (cost unspecified)	~$9.50 / under £10	Affordability is a genuine advantage for a moisturising eye cream

What Exactly Is PDRN, and Why Is Everyone Suddenly Talking About It?

PDRN stands for polydeoxyribonucleotide: a mixture of DNA-derived polymer fragments with molecular weights typically ranging from roughly 50 to 1,500 kDa, most commonly purified from the sperm DNA of salmon trout (Oncorhynchus mykiss) or chum salmon (Oncorhynchus keta). The purification process strips out proteins and peptides that could provoke immune reactions, leaving behind the nucleotide chains themselves.

Its proposed mechanism has two parts. First, PDRN is thought to engage the adenosine A2A receptor, where its anti-inflammatory and tissue-repair signalling is believed to originate. Second, it supplies nucleosides and nucleotides to the cellular salvage pathway — essentially handing skin cells pre-made DNA building blocks rather than requiring them to synthesise their own. Both mechanisms are plausible and supported by pharmacological research, but they were originally studied in the context of injected drugs for wound healing, not leave-on cosmetics.

The ingredient entered mainstream beauty through Korean aesthetic clinics, where "salmon DNA" injections and "PDRN facials" became popular for skin rejuvenation. From there it migrated into K-beauty serums, masks, and eye creams, and by 2026 it had crossed into Western retail at scale. K-Beauty Clarity notes that PDRN fits several converging trends — barrier-focused routines, "slow aging" positioning, post-treatment-inspired skincare, and a general appetite for peptide and regenerative-style ingredients — which explains the speed of its commercial rise.

What the marketing often collapses is the distinction between injected PDRN (a regulated drug placed directly into the dermis) and topical PDRN (a cosmetic ingredient that must cross the intact skin barrier to reach living tissue). As James Kace MD explains, a material that supports injured tissue or skin recovering from a professional procedure does not automatically produce a visible anti-aging result when placed in an over-the-counter serum and applied to intact skin. The delivery method changes the question entirely.

What Does the Clinical Evidence for Topical PDRN Actually Show?

Until late 2025, most published human evidence for PDRN involved injections, not topical application. A systematic review of injectable aesthetic PDRN use identified nine studies covering 219 patients, with promising outcomes for wrinkles, texture, and elasticity — but the authors rated the evidence low to moderate quality, and variation in technique made meta-analysis impossible. That is real, encouraging data for professionally delivered polynucleotides. It is not proof that a serum applied at home behaves the same way.

The topical picture changed with two studies:

The Peony PDRN Study (December 2025): Researchers investigated a low-molecular-weight PDRN derived from Paeonia lactiflora (a plant source, not salmon). Topical use improved periorbital skin elasticity after four weeks in a small human study. The catch: the study was small, all six authors worked for the company that makes the ingredient, and the material is not what most products on shelves contain.

The Ye et al. PDRN-850K Eye Cream Trial (July 2026): This is the study that genuinely shifted the conversation. Published in PLOS ONE, it was a randomized, double-blind, split-face trial in 31 Chinese women aged 35–55 (average age 47.5), all with visible crow's feet, under-eye lines, and eye bags. Each participant applied a 0.1% medium-length PDRN eye cream to one side of the face and an identically formulated 0.1% retinol cream to the other, twice daily for 28 days.

Results on the PDRN side were notable across multiple instruments:

Crow's-feet wrinkle area and number fell by up to 23%, compared with about 6–7% on the retinol side
Skin elasticity improved by +44.0% on the PDRN side versus +24.8% with retinol
Dermal thickness increased by 11.5% (PDRN) versus 5.5% (retinol) by ultrasound
Firmness improved 29.6% versus 16.3%
Results were already measurably better on the PDRN side by day 14 — more than the retinol side achieved by day 28

The researchers also used confocal Raman spectroscopy to separately assess skin penetration, which directly addresses the longstanding objection that PDRN molecules are too large to cross the stratum corneum. For this specific 850 kDa preparation, penetration was confirmed.

This study deserves genuine attention. It challenges the assumption that a DNA-derived molecule cannot have meaningful topical activity and provides a stronger bridge between laboratory findings and visible cosmetic outcomes than anything published before it. Skingenetix's appraisal, medically reviewed by Dr. Esther Bodde, calls it "the only controlled trial of PDRN on intact skin, and a strong result."

But the study does not settle the category. It evaluated one defined material — a high-purity, medium-length preparation capped at 850 kDa — at one concentration (0.1%), in one specific eye-cream formula, over 28 days, in 31 participants. As James Kace MD notes, the researchers acknowledged that longer studies are needed to determine whether results endure and to distinguish early hydration or plumping effects from sustained dermal remodeling.

Does The Ordinary Lacto-PDRN 4% + B9 Eye Cream Deliver on Its Claims?

The Ordinary Lacto-PDRN 4% + B9 Eye Cream retails for approximately $9.50 and promises to firm sagging eyelids, smooth wrinkles, and make the eye area look younger. It is one of the most affordable PDRN-labeled eye creams on the market. Whether it delivers on the PDRN science specifically is a more complicated question.

The PDRN in this product is not the same as in the clinical trial. The Ordinary uses a vegan version made by fermenting bacteria — listed on the ingredient label as Sodium DNA — rather than the salmon-derived PDRN-850K used in the Ye et al. study. The "4%" on the label refers to The Ordinary's proprietary Lacto-PDRN blend, a mixture of ingredients, not 4% pure DNA fragments. As Beautiful With Brains explains, you cannot assume you are getting 40 times more PDRN than the cream used in the study.

That does not make the product bad — it just means the anti-aging claims rest on thinner ice than the marketing implies.

The immediate firmness you feel after applying this cream comes not from PDRN but from two film-forming ingredients: pullulan (a sugar-based ingredient produced through fermentation) and Acacia Senegal Gum (derived from the acacia tree). These ingredients form a thin film over the skin surface. As that film settles, it creates a tightening sensation that makes fine lines and crepey eyelids look smoother — think of it as shapewear for the eye area. Everything looks tighter while the film is present, but nothing underneath has structurally changed. Wash off the cream, and the tightening effect goes with it.

The hydration is real and useful. The formula contains glycerin and shea oil, both well-established moisturising ingredients with solid evidence behind them. The lightweight gel-cream texture absorbs quickly, leaves no greasy residue, and works well under makeup — concealer applies more smoothly over the hydrated, less-crepey skin surface. For an eye cream under £10, that is genuinely good performance.

Vitamin B9 (folic acid) is a supporting player, not a headliner. Folic acid helps the body make DNA and produce new cells, and a 2008 study found that a cream containing folic acid and creatine improved skin firmness, reduced wrinkles, and helped protect against UV damage. That study used both ingredients together, making it impossible to attribute the results to folic acid alone. It is not a reason to dismiss the ingredient, but it is not a reason to buy this cream for folic acid specifically.

Brand Claim	Assessment
"Firm, hydrate and visibly lift the eye area"	Mostly true — hydration is real; visible lift comes from film-formers, not PDRN
"Improve skin firmness and elasticity"	Unproven for this specific formula; the word "helps" is doing heavy lifting
"Lightweight gel-cream for easy layering with makeup"	True — texture performs well in practice

How Does PDRN Compare to Retinol for Eye-Area Aging?

The Ye et al. trial set up a direct comparison, and the results favored PDRN on every measured parameter over 28 days. Crow's-feet wrinkle area fell roughly three times more on the PDRN side than on the retinol side. Elasticity, firmness, and dermal thickness all showed larger gains with PDRN. No adverse reactions were reported on either side — notable, because retinol commonly causes irritation, redness, and peeling, particularly in the thin, sensitive skin around the eyes.

This does not mean PDRN has replaced retinol as the gold standard for anti-aging. Retinol has decades of evidence across thousands of participants in multiple study designs. The PDRN trial is one study, 31 participants, 28 days. As K-Beauty Clarity cautions, the results cannot automatically be applied to every PDRN serum, cream, toner, or mask — they apply to the specific 0.1% PDRN-850K preparation tested.

What the trial does establish is that dismissing topical PDRN as "too large to penetrate skin" is no longer accurate for all preparations. Molecular weight and formulation matter enormously. A low-molecular-weight or medium-length PDRN in a purpose-built delivery system can behave very differently from an undisclosed PDRN concentration in a generic cream base.

For the eye area specifically, PDRN's tolerability advantage over retinol is worth noting. The periocular skin is among the thinnest on the face, and retinol-related irritation is common there. If a well-formulated PDRN eye cream can deliver comparable or superior results without the irritation risk, that is a clinically meaningful difference — provided the formulation is the right one.

What Should You Look for When Buying a PDRN Eye Cream?

The evidence makes clear that not all PDRN eye creams are equivalent. Clinic Japan's assessment frames the right question: "Ask which preparation." Here is what that means in practice.

Molecular weight matters. The Ye et al. trial used PDRN capped at 850 kDa — a medium-length preparation specifically chosen for its ability to penetrate the skin barrier. Standard salmon-derived PDRN can range up to 1,500 kDa, which is far too large to cross intact skin in meaningful quantities. Products that disclose molecular weight or reference a specific PDRN preparation (e.g., PDRN-850K) are making a more honest claim than those that simply list "PDRN" or "Sodium DNA" without further detail.

Concentration is not always what it seems. The effective concentration in the clinical trial was 0.1%. A product listing "4% Lacto-PDRN" may contain far less actual PDRN if that percentage refers to a proprietary blend. Look for transparency about what the percentage actually measures.

Source affects the evidence base. Salmon-derived PDRN is what the clinical literature primarily covers. Vegan alternatives made through bacterial fermentation (like The Ordinary's version) or plant-derived preparations (like the peony PDRN studied in 2025) may be promising, but they carry a larger evidence gap. That does not make them ineffective — it means less is known.

The rest of the formula still matters. Herbal Dynamics Beauty makes this point clearly: moisture-related plumping and durable changes to skin structure are different outcomes. A cream that hydrates well with glycerin, ceramides, or peptides will make fine lines look better immediately. Whether PDRN is doing anything additional on top of that requires a controlled study — and most products have not been tested that way.

Dermatologist skepticism is warranted but not absolute. Dr. Dray, a board-certified dermatologist with nearly 27 million YouTube subscribers, has reviewed PDRN skincare products and expressed skepticism about topical PDRN's ability to penetrate skin. That skepticism was well-founded before the 2026 trial — and the trial's penetration data partially addresses it for that specific preparation. The honest position in late 2026 is that topical PDRN is no longer evidence-free, but the evidence is narrow and preparation-specific.

Who Should Actually Buy a PDRN Eye Cream Right Now?

PDRN eye cream is worth considering if you want a well-formulated, hydrating eye treatment and are curious about an emerging ingredient with genuinely interesting early evidence. It is not worth buying if you expect it to permanently reverse deep wrinkles or lift structurally sagging eyelids — no topical cosmetic can do that, PDRN or otherwise.

For a budget-conscious buyer, The Ordinary Lacto-PDRN 4% + B9 Eye Cream at under £10 is a reasonable choice as a moisturising eye cream that temporarily smooths fine lines. Beautiful With Brains' reviewer rates it 4/5 and recommends buying it for the instant results and pleasant texture, not for the anti-aging science. That is an honest framing.

Someone specifically seeking the PDRN benefits demonstrated in the clinical trial should look for a product that uses a defined medium-length PDRN preparation at approximately 0.1% concentration — ideally with published penetration data or a reference to the specific PDRN-850K material. Those products exist but tend to cost more and are less widely available in mainstream retail.

Herbal Dynamics Beauty's guidance on mature skin is worth keeping in mind: keep the foundation clear — gentle cleansing, a suitable moisturizer, and daily sun protection. PDRN can be an optional topical step if its formula fits your preferences and tolerance. It should not replace several established steps at once, and it should not be evaluated against the results of injectable treatments or professional procedures.

The Bottom Line: Promising Ingredient, Narrow Evidence, Formulation-Dependent Results

PDRN is a DNA-derived ingredient with a plausible biological mechanism and, as of 2026, at least one well-designed topical clinical trial behind it. The Ye et al. study is the strongest evidence yet that a specific topical PDRN preparation can outperform retinol on crow's feet and periocular skin metrics over 28 days — a meaningful scientific development.

What it is not is proof that every product labeled "PDRN" will deliver those results. The evidence attaches to a specific molecular weight (≤850 kDa), a specific concentration (0.1%), a specific source (high-purity salmon-derived), and a specific finished formula — not to the ingredient category as a whole. As K-Beauty Clarity summarizes, "formulation and delivery matter far more than simply seeing 'PDRN' on the front of a bottle."

For the eye area specifically, the ingredient's tolerability profile is genuinely attractive. If longer studies confirm that the 28-day results persist and extend to broader populations, PDRN could become a meaningful alternative to retinol for people who cannot tolerate retinol's irritation around the eyes. That is a real possibility worth watching — just not a certainty worth overpaying for today.

If you are building a broader anti-aging skincare routine, consider pairing an eye cream with a well-formulated plumping or collagen-boosting serum for the rest of the face, where the evidence base for established ingredients like retinol, vitamin C, and peptides is considerably deeper.